The CRISPR expertise center at Cancer Center Amsterdam, Amsterdam UMC supports scientists and clinicians to implement state-of-the-art gene editing technologies for the rapid advancement of fundamental, translational, and pre-clinical studies. Sign up for our monthly newsletter to stay informed about the fast-moving developments in the field of CRISPR.

In the last decade, CRISPR/Cas gene editing technology has delivered on its promise and has developed into a multifunctional powerhouse for basic and translational research in all life sciences. With early data from gene editing in clinical trials trickling in, it appears we are now on the verge of a new era in which CRISPR technology will be used as therapy to make beneficial changes to patient DNA and combat disease.

In the monthly CRISPR newsletter, we highlight significant scientific advancements in the fast-developing field of CRISPR, including:

  • Scientific highlights: CRISPR empowered research breakthroughs in human life sciences
  • CRISPR screens: highlights of genome-wide functional screens
  • CRISPR diagnostics
  • CRISPR clinical trials
  • Tools: new or greatly improved CRISPR methods
  • Upcoming scientific meetings involving CRISPR technology

For more information contact Dr. Rodrigo Oliveira (r.ld.oliveira@amsterdamumc.nl), manager CRISPR Expertise Center, or sign up for the CRISPR newsletter composed by Henri van de Vrugt at CRISPR@amsterdamumc.nl